CANTON TWP.–MMS Holdings, a contract research organization, announced an expansion of its leadership team with the appointment of Chris Schoonmaker as COO and Ashu Tandon as chief commercial officer.
Both Schoonmaker and Tandon have decades of experience in the pharmaceutical and healthcare industry and have held leadership positions at other CROs.
“We are excited to welcome Chris and Ashu to the OneMMS team,” said Uma Sharma, MMS CEO. “I look forward to their leadership and strength for our continued growth as we scale our teams and clients globally to be the best in business.”
The expansion of the MMS executive leadership team, including the newly created position of chief commercial officer, will allow the company to continue growing its teams and services across its global operations.
“I’m excited to join and help expand MMS’ reach as we continue to bring value to Sponsors by helping them bring new therapies to market,” Tandon said. “We have strong expertise across our many services, and I look forward to connecting Sponsors with the MMS services that are the right fit for their needs.”
MMS has maintained one of the highest retention rates in the pharma industry and a positive colleague culture since its inception. These aspects of MMS enhance its mission of delivering high-quality service and technology solutions to assist clients in developing life-changing therapies.
“I’m grateful to work at a company with such a strong company culture that cares about its colleagues,” said Schoonmaker. “Being a part of growing the company and developing the business strategies and operational excellence needed to continue our success is exciting and rewarding to me after many years in this space.”
More at www.mmsholdings.com.